6 completed. 2 Phase 2, 2 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Twenty-Nail Dystrophy: new trials by email Literature Review of Twenty-Nail Dystrophy trials Research Report on Twenty-Nail Dystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments Veg Collagen Peptide, Bovine Collagen Peptide, Fish | Marine Collagen Peptide - Mild to Moderate Acne, Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1 | Not applicable | Completed | NovoBliss Research Pvt Ltd | 264 | 2023-01-11 | 2023-12-12 |
| Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 604 | 2011-02-01 | 2019-04-03 |
| Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 594 | 2010-12-01 | 2019-02-22 |
| Topical Cyclosporine Suspension for the Treatment of Brittle Nails topical cyclosporine ophthalmic suspension 0.05%, vehicle - Brittle Nail Syndrome | Phase 2 | Completed | University of North Carolina, Chapel Hill | 21 | 2010-02-01 | 2017-03-13 |
| Restasis for Treatment of Brittle Nails Restasis (cyclosporine ophthalmic emulsion) 0.05%, Refresh® Dry Eye therapy - Brittle Nails | Phase 2 | Completed | Julian M. Mackay-Wiggan | 24 | 2009-07-01 | 2013-08-20 |
| Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails Tazorac - Brittle Nails | Phase 4 | Completed | Columbia University | 20 | 2005-08-01 | 2014-07-02 |
Foot Dermatoses (2) · Keratoderma, Palmoplantar, Epidermolytic (2) · Nails, Malformed (2) · Onycholysis (2) · Onychomycosis (2) · Yellow Nail Syndrome (2) · Acne Vulgaris (1) · Arthralgia (1) · Enterocolitis, Necrotizing (1) · Osteoarthritis, Knee (1)
Pathological Conditions, Signs and Symptoms (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Bacterial Infections and Mycoses (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dermatomycoses (2) · Foot Diseases (2) · Genetic Diseases, Inborn (2) · Infections (2) · Keratoderma, Palmoplantar (2) · Keratoderma, Palmoplantar, Diffuse (2) · Keratosis (2) · Mycoses (2) · Nail Diseases (2) · Pathological Conditions, Anatomical (2)
Cyclosporins (2) · Solutions (2) · tazarotene (1)
Pfizer (2) · Columbia University (1) · Julian M. Mackay-Wiggan (1) · NovoBliss Research Pvt Ltd (1) · University of North Carolina, Chapel Hill (1)
United States (5) · Canada (1) · India (1)
Aida Lugo-Somolinos, MD (1) · Dr Nayan K Patel, MBBS (1) · Julian Mackay Wiggan, MD, MS (1) · Julian Mackay-Wiggan, MD (1) · Richard Scher, MD (1)